NEW YORK, May 18, 2011 /PRNewswire/ -- Oppenheimer &
Co. Inc., a unit of Oppenheimer Holdings, is pleased to announce
that Matthias Spaenle, MD will join the firm as Managing Director
in the Healthcare group of the Firm's Investment Bank, where he
will help to drive its life science business. He will report to
Brian McCarthy, Managing Director
and Head of Healthcare Investment Banking.
Since 2003, Matthias had worked at JMP Securities, where he was
a Senior Calling Officer in the Healthcare Group and had focused on
biotechnology. Prior to working at JMP, he had worked for Robertson
Stephens. A graduate of the Ross School of Business, the
University of Michigan, Matthias
initially trained in general surgery at the University Hospital
Cologne in Cologne, Germany.
"Matthias is an experienced and highly regarded senior banker in
the life science space. We are delighted that he's joining our
healthcare investment banking team," Mr. McCarthy concluded.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary
of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange),
provides a full range of wealth management, securities brokerage
and investment banking services to high-net-worth individuals,
families, corporate executives, local governments, businesses and
institutions.
Certain statements in this release may constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve
a number of risks, uncertainties and other factors that could cause
actual results to differ materially, as discussed in the Company's
filings with the Securities and Exchange Commission.
SOURCE Oppenheimer & Co. Inc.